136 related articles for article (PubMed ID: 25546196)
1. FDG PET/CT of neuroendocrine carcinoma of the thyroid gland.
Zheng LC; OuYang XL; Zhang WJ; Zhang XM
Clin Nucl Med; 2015 Feb; 40(2):146-8. PubMed ID: 25546196
[TBL] [Abstract][Full Text] [Related]
2. Isolated adrenal metastasis of small cell neuroendocrine carcinoma of the ovary detected with FDG-PET/CT.
Ozpacaci T; Tamam MO; Mulazimoglu M; Kamali G; Ozcan D
Rev Esp Med Nucl Imagen Mol; 2012 Sep; 31(5):297-8. PubMed ID: 23067537
[No Abstract] [Full Text] [Related]
3. Ultrasound stratification of the FDG-avid thyroid nodule.
Beech P; Lavender I; Jong I; Soo G; Ramdave S; Chong A; Nandurkar D
Clin Radiol; 2016 Feb; 71(2):164-9. PubMed ID: 26683088
[TBL] [Abstract][Full Text] [Related]
4. Clinical value of [(18)F]FDG-PET/CT in the detection of metastatic medullary thyroid cancer.
Jiang J; Yang Z; Zhang Y; Xu X; Wang M; Hu S; Yao Z; Pan H; Zhang Y; Li D
Clin Imaging; 2014; 38(6):797-801. PubMed ID: 24973077
[TBL] [Abstract][Full Text] [Related]
5. A rare case of large cell neuroendocrine carcinoma of the urinary bladder evaluated by ¹⁸F-FDG-PET/CT.
Treglia G; Paone G; Flores B; Venzi G; Ceriani L; Giovanella L
Rev Esp Med Nucl Imagen Mol; 2014; 33(5):312-3. PubMed ID: 24440201
[No Abstract] [Full Text] [Related]
6.
Ruhlmann M; Ruhlmann J; Görges R; Herrmann K; Antoch G; Keller HW; Ruhlmann V
Thyroid; 2017 Oct; 27(10):1300-1306. PubMed ID: 28793848
[TBL] [Abstract][Full Text] [Related]
7. Thyroid incidentalomas detected on 18F-fluorodeoxyglucose-positron emission tomography/computed tomography: Thyroid Imaging Reporting and Data System (TIRADS) in the diagnosis and management of patients.
Yoon JH; Cho A; Lee HS; Kim EK; Moon HJ; Kwak JY
Surgery; 2015 Nov; 158(5):1314-22. PubMed ID: 25958065
[TBL] [Abstract][Full Text] [Related]
8. Metastatic undifferentiated spindle cell sarcoma of the thyroid gland evaluated by 18F-FDG PET/CT.
Treglia G; Bongiovanni M; Paone G; Ceriani L; Giovanella L
Clin Nucl Med; 2015 Mar; 40(3):e208-10. PubMed ID: 25140545
[TBL] [Abstract][Full Text] [Related]
9. Recurrent lymphoma in the thyroid gland detected by fluorine-18-fluorodeoxyglucose PET/CT.
Treglia G; Del Ciello A; Di Franco D
Endocrine; 2013 Feb; 43(1):242-3. PubMed ID: 22948774
[No Abstract] [Full Text] [Related]
10. Thyroid nodules with indeterminate cytology: prospective comparison between 18F-FDG-PET/CT, multiparametric neck ultrasonography, 99mTc-MIBI scintigraphy and histology.
Piccardo A; Puntoni M; Treglia G; Foppiani L; Bertagna F; Paparo F; Massollo M; Dib B; Paone G; Arlandini A; Catrambone U; Casazza S; Pastorino A; Cabria M; Giovanella L
Eur J Endocrinol; 2016 May; 174(5):693-703. PubMed ID: 26966173
[TBL] [Abstract][Full Text] [Related]
11. Intravascular small cell neuroendocrine tumor in the neck.
Chang CA; Jong I; Nowicki A; Ramdave S
Clin Nucl Med; 2014 Nov; 39(11):988-9. PubMed ID: 24978335
[TBL] [Abstract][Full Text] [Related]
12. High CEA levels in a case of resected colorectal cancer: delayed diagnosis of metachronous medullary thyroid cancer.
Chen SW; Chen YK
World J Surg Oncol; 2017 Dec; 15(1):230. PubMed ID: 29284496
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of FDG-PET/CT for cytologically indeterminate thyroid nodules: a decision analytic approach.
Vriens D; Adang EM; Netea-Maier RT; Smit JW; de Wilt JH; Oyen WJ; de Geus-Oei LF
J Clin Endocrinol Metab; 2014 Sep; 99(9):3263-74. PubMed ID: 24873995
[TBL] [Abstract][Full Text] [Related]
14. Effect of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-guided management of suspected recurrent papillary thyroid carcinoma: long-term follow-up with tumour marker responses.
Dennis K; Hay JH; Wilson DC
Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e168-72. PubMed ID: 22944464
[TBL] [Abstract][Full Text] [Related]
15. Comparison of F-18 FDG-PET/CT and Tc-99m MIBI in the preoperative evaluation of cold thyroid nodules in the same patient group.
Sager S; Vatankulu B; Erdogan E; Mut S; Teksoz S; Ozturk T; Sonmezoglu K; Kanmaz B
Endocrine; 2015 Sep; 50(1):138-45. PubMed ID: 25795290
[TBL] [Abstract][Full Text] [Related]
16. Multimodal imaging with (18)F-FDG-PET/CT and (111)In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma.
De Luca S; Fonti R; Camera L; Salvatore B; Faggiano A; Ciarmiello A; Segreto S; Colao A; Salvatore M; Del Vecchio S
Ann Nucl Med; 2016 Apr; 30(3):234-41. PubMed ID: 26753628
[TBL] [Abstract][Full Text] [Related]
17. Preoperative evaluation of thyroid nodules with 18FDG-PET/CT.
Mitchell JC; Grant F; Evenson AR; Parker JA; Hasselgren PO; Parangi S
Surgery; 2005 Dec; 138(6):1166-74; discussion 1174-5. PubMed ID: 16360405
[TBL] [Abstract][Full Text] [Related]
18. Impact of FDG-PET computed tomography for surgery of recurrent or persistent differentiated thyroid carcinoma.
Weber T; Ohlhauser D; Hillenbrand A; Henne-Bruns D; Reske SN; Luster M
Horm Metab Res; 2012 Nov; 44(12):904-8. PubMed ID: 22791600
[TBL] [Abstract][Full Text] [Related]
19. Primary squamous cell carcinoma of the thyroid on FDG PET/CT.
Cai L; Chen Y; Huang Z; Wu J
Clin Nucl Med; 2014 Nov; 39(11):1014-6. PubMed ID: 24999700
[TBL] [Abstract][Full Text] [Related]
20. Role of positron emission tomography/computed tomography in adrenal and neuroendocrine tumors: fluorodeoxyglucose and nonfluorodeoxyglucose tracers.
Wong KK; Arabi M; Zerizer I; Al-Nahhas A; Rubello D; Gross MD
Nucl Med Commun; 2011 Sep; 32(9):764-81. PubMed ID: 21799367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
